companydata.dkONCONOX ApS: Financial statements 2015
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK 1,450,157 compared with DKK -49,757 the year before. Equity amounted to DKK 1,010,064. The solvency ratio was 97.2%.
- Profit/Loss
- 1,450,157 kr.
- Equity
- 1,010,064 kr.
- Total Assets
- 1,039,625 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | 1.5 mio. | 1 mio. | - |
| 2014 | - | - | -50 t. | -93 | - |
| 2013 | - | - | -191 t. | 50 t. | - |
| 2012 | - | -705 t. | -712 t. | 240 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
ONCONOX ApS has published its annual report for 2014. The net result was DKK -49,757.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.